Notably, a previous study comparing parathyroid adenoma, non‐metastatic and metastatic PC found that FGFR1 is one of the genes overexpressed in metastatic versus non‐metastatic PC, also emphasizing FGFR1 inhibition as a potential therapeutic strategy [46]. The gene discussed is FGFR1; the disease is pachyonychia congenita.